Min Fang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Min Fang has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Jian-Ping Liu
Centre for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, China
5 shared publications - Chang-Hao Liang
Centre for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China
2 shared publications - Hui-Di Lan
School of Traditional Medicine, Guangxi University of Chinese Medicine, No. 13 Wu He Da Dao, Nanning, Guangxi 530000, China
2 shared publications - Lingyao Kong
Centre for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China
2 shared publications - Mei Han
Centre for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China
2 shared publications - Ning Dai
Centre for Evidence-Based Chinese Medicine, School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China
2 shared publications
Latest Publications
- 29 March 2023
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
The effect of external treatment of traditional Chinese medicine in overweight or simple obese patients: An umbrella review of meta-analyses of randomized controlled trials
Review question / Objective: What is the efficacy and safety of external treatment of Traditional Chinese medicine(ET-TCM) for overweight or simple obesity? What is the current state of the available evidence? What is the level of evidence? Information sources: Eight electronic databases (PubMed, Embase, Web of science, Cochrane library, CNKI, VIP, Wan Fang, CBM) and references included in the studies were used to supplement.eight lectronic database(PubMed, Embase, Web of science, Cochrane library, CNKI, VIP, Wan Fang, CBM ) and references for inclusion in the literature to supplement.
- 29 March 2023
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
The effect of external treatment of traditional Chinese medicine in overweight or simple obese patients: An umbrella review of meta-analyses of randomized controlled trials
Review question / Objective: What is the efficacy and safety of external treatment of Traditional Chinese medicine(ET-TCM) for overweight or simple obesity? What is the current state of the available evidence? What is the level of evidence? Information sources: Eight electronic databases (PubMed, Embase, Web of science, Cochrane library, CNKI, VIP, Wan Fang, CBM) and references included in the studies were used to supplement.eight lectronic database(PubMed, Embase, Web of science, Cochrane library, CNKI, VIP, Wan Fang, CBM ) and references for inclusion in the literature to supplement.
- 17 August 2022
- Published by Springer Nature in Quality of Life Research
- Vol. 32 (3) , 653-667
Therapeutic massage/Tuina for treatment of functional dyspepsia: a systematic review and meta-analysis of randomized controlled trials
Purpose A systematic review of randomized controlled trials (RCTs) was conducted to assess the potential effect of therapeutic massage/Tuina on functional dyspepsia (FD) patients. Method Twelve databases and three clinical trial registries were searched until December 2021, for RCTs that compared Tuina combined with or without conventional therapy versus conventional therapy in FD. We assessed the methodological quality of included trials by the Cochrane Risk of Bias tool, and graded the quality of the evidence. The data were presented as risk ratio (RR) or mean difference (MD) respectively with their 95% confidence interval (CI). Results In total, 14 RCTs with 1128 FD participants were included. Compared with conventional therapy, Tuina showed significant beneficial effects on improving overall symptom (RR = 1.12, 95% CI 1.06 to 1.19, low certainty evidence), and early satiation (MD −0.44 scores, 95% CI −0.72 to −0.16, very low certainty evidence). Compared with conventional therapy, Tuina plus conventional therapy also significantly improved overall symptom (RR = 1.14, 95% CI 1.06–1.23, low certainty evidence), quality of life (MD 10.44 scores, 95% CI 7.65–13.23, low certainty evidence), and epigastric pain (MD −0.76 scores, 95% CI −1.11 to −0.41, low certainty evidence). No adverse events related to Tuina and cost-effectiveness were reported. Conclusion Low certainty evidence showed that Tuina significantly improved overall symptom of FD participants compared with conventional therapy. Low certainty evidence showed that Tuina plus conventional therapy obviously improved overall symptom and quality of life of FD participants compared with conventional therapy.
- 17 August 2022
- Published by Springer Nature in Quality of Life Research
- Vol. 32 (3) , 653-667
Therapeutic massage/Tuina for treatment of functional dyspepsia: a systematic review and meta-analysis of randomized controlled trials
Purpose A systematic review of randomized controlled trials (RCTs) was conducted to assess the potential effect of therapeutic massage/Tuina on functional dyspepsia (FD) patients. Method Twelve databases and three clinical trial registries were searched until December 2021, for RCTs that compared Tuina combined with or without conventional therapy versus conventional therapy in FD. We assessed the methodological quality of included trials by the Cochrane Risk of Bias tool, and graded the quality of the evidence. The data were presented as risk ratio (RR) or mean difference (MD) respectively with their 95% confidence interval (CI). Results In total, 14 RCTs with 1128 FD participants were included. Compared with conventional therapy, Tuina showed significant beneficial effects on improving overall symptom (RR = 1.12, 95% CI 1.06 to 1.19, low certainty evidence), and early satiation (MD −0.44 scores, 95% CI −0.72 to −0.16, very low certainty evidence). Compared with conventional therapy, Tuina plus conventional therapy also significantly improved overall symptom (RR = 1.14, 95% CI 1.06–1.23, low certainty evidence), quality of life (MD 10.44 scores, 95% CI 7.65–13.23, low certainty evidence), and epigastric pain (MD −0.76 scores, 95% CI −1.11 to −0.41, low certainty evidence). No adverse events related to Tuina and cost-effectiveness were reported. Conclusion Low certainty evidence showed that Tuina significantly improved overall symptom of FD participants compared with conventional therapy. Low certainty evidence showed that Tuina plus conventional therapy obviously improved overall symptom and quality of life of FD participants compared with conventional therapy.
- 31 January 2022
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
Gynostemma Pentaphyllum for Dyslipidemia: A protocol of Systematic Review of Randomized Controlled Trials
Review question / Objective: The aim of this systematic review is to compare Chinese herb Gynostemma pentaphyllum with no treatment, placebo, lipid-lowering agents, or other Chinese herbal products that containing red yeast rice extracts to evaluate effectiveness, safety and cost-effectiveness in people with dyslipidemia to inform clinical practice. To this end, the proposed systematic review will address the following question: Is Chinese herb Gynostemma pentaphyllum effective for dyslipidemia? Information sources: The PubMed, the Cochrane Library, EMBASE, Web of Science, China National Knowledge Infrastructure (CNKI), Chinese Scientific Journal Database (VIP), SinoMed, and Wanfang Data will be searched in January 2022. We also explored the World Health Organization International Clinical Trials Registry Platform (https://www.who.int/clinical-trials-registry-platform), ClinicalTrials.gov (www.clinicaltrials.gov/), and the Chinese Clinical Trial Registry (http://www.chictr.org.cn/index.aspx) for ongoing or unpublished trials to January 2022. Subject words or text words are determined based on published systematic reviews, clinical practice guidelines, ICD-10, ICD-11, MeSH terms, and Emtree. In addition, the reference lists of all identified studies will also be searched to find any relevant trials for inclusion.
- 31 January 2022
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
Gynostemma Pentaphyllum for Dyslipidemia: A protocol of Systematic Review of Randomized Controlled Trials
Review question / Objective: The aim of this systematic review is to compare Chinese herb Gynostemma pentaphyllum with no treatment, placebo, lipid-lowering agents, or other Chinese herbal products that containing red yeast rice extracts to evaluate effectiveness, safety and cost-effectiveness in people with dyslipidemia to inform clinical practice. To this end, the proposed systematic review will address the following question: Is Chinese herb Gynostemma pentaphyllum effective for dyslipidemia? Information sources: The PubMed, the Cochrane Library, EMBASE, Web of Science, China National Knowledge Infrastructure (CNKI), Chinese Scientific Journal Database (VIP), SinoMed, and Wanfang Data will be searched in January 2022. We also explored the World Health Organization International Clinical Trials Registry Platform (https://www.who.int/clinical-trials-registry-platform), ClinicalTrials.gov (www.clinicaltrials.gov/), and the Chinese Clinical Trial Registry (http://www.chictr.org.cn/index.aspx) for ongoing or unpublished trials to January 2022. Subject words or text words are determined based on published systematic reviews, clinical practice guidelines, ICD-10, ICD-11, MeSH terms, and Emtree. In addition, the reference lists of all identified studies will also be searched to find any relevant trials for inclusion.
- Open Access
- 10 November 2021
- Published by Elsevier in Integrative Medicine Research
- Vol. 11 (2) , 100806
Chinese herbal medicine for myasthenia gravis: A systematic review and meta-analysis of randomized clinical trials
- 10 November 2021
- Published by Elsevier in Integrative Medicine Research
- Vol. 11 (2) , 100806
Open AccessChinese herbal medicine for myasthenia gravis: A systematic review and meta-analysis of randomized clinical trials
- Open Access
- 19 October 2021
- Published by Elsevier in Integrative Medicine Research
- Vol. 10 (Suppl) , 100798
Traditional Chinese medicine for COVID-19 pandemic and emerging challenges: An online cross-sectional survey in China
- 19 October 2021
- Published by Elsevier in Integrative Medicine Research
- Vol. 10 (Suppl) , 100798
Open AccessTraditional Chinese medicine for COVID-19 pandemic and emerging challenges: An online cross-sectional survey in China
- Open Access
- 1 August 2021
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 60, 102744
Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials
- 1 August 2021
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 60, 102744
Open AccessTherapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials
- 1 September 2001
- Published by Wiley in Water Environment Research
- Vol. 73 (5) , 633-638
Seeding Effect on Cocomposting Wastewater Biosolids with Coal Fly Ash
The seeding effect on fly ash‐amended biosolids composting was evaluated by inoculating a mixture of ash and biosolids with seeding materials before composting. These inocula included thermophilic bacteria (Bacillus. brevis, B. coagulans, and B. licheniformis) isolated from the ash–biosolids compost, a commercial decomposter, and recycled biosolids compost. Although the addition of these microbial additives to the ash–biosolids compost improved the population of thermophilic bacteria at the early stage of composting, the improvement was negligible after 4 days of composting. Inoculation with isolated bacterial culture, milk powder, or the decomposter, only, did not effectively improve the decomposition of organic matter compared with those receiving inoculation of both microbial additives and milk powder together. The isolated Bacillus species was as efficient as the commercial decomposter in accelerating the decomposition rate during ash‐amended biosolids composting as indicated by the high amounts of carbon dioxide evolved and cumulative weight loss. Ash–biosolids compost inoculated with 15% (dry weight basis) of recycled compost showed a comparable decomposition activity to those inoculated with bacterial culture and the commercial decomposter with milk powder. Taking into consideration the lower operating cost and acceptable decomposition efficiency, recycled biosolids compost seemed to be a promising additive to ash‐amended biosolids compost to improve composting efficiency.
- 1 September 2001
- Published by Wiley in Water Environment Research
- Vol. 73 (5) , 633-638
Seeding Effect on Cocomposting Wastewater Biosolids with Coal Fly Ash
The seeding effect on fly ash‐amended biosolids composting was evaluated by inoculating a mixture of ash and biosolids with seeding materials before composting. These inocula included thermophilic bacteria (Bacillus. brevis, B. coagulans, and B. licheniformis) isolated from the ash–biosolids compost, a commercial decomposter, and recycled biosolids compost. Although the addition of these microbial additives to the ash–biosolids compost improved the population of thermophilic bacteria at the early stage of composting, the improvement was negligible after 4 days of composting. Inoculation with isolated bacterial culture, milk powder, or the decomposter, only, did not effectively improve the decomposition of organic matter compared with those receiving inoculation of both microbial additives and milk powder together. The isolated Bacillus species was as efficient as the commercial decomposter in accelerating the decomposition rate during ash‐amended biosolids composting as indicated by the high amounts of carbon dioxide evolved and cumulative weight loss. Ash–biosolids compost inoculated with 15% (dry weight basis) of recycled compost showed a comparable decomposition activity to those inoculated with bacterial culture and the commercial decomposter with milk powder. Taking into consideration the lower operating cost and acceptable decomposition efficiency, recycled biosolids compost seemed to be a promising additive to ash‐amended biosolids compost to improve composting efficiency.